Bart JF van den Bemt

The frequency and impact of drug-related problems with postoperative medication reported by orthopaedic patients after discharge

Eward J Melis, Bart JF van den Bemt, Dirk E. Schrander, Johanna E Vriezekolk

Following orthopaedic surgery, medication is vital for recovery and preventing complications, however drug-related problems (DRPs) can hinder medication use. The prevalence, types, and impact of DRPs on patients' activities of daily living (ADL) and the medication involved are unknown. Insight is needed …

nl (code pays fourni par la source)

Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial

Nathan den Broeder, Lise M Verhoef, Yaël A de Man, Marc R. Kok et autres

BACKGROUND: The REDO trial (REtreatment with Rituximab in RhEmatoid arthritis: Disease Outcome after Dose Optimisation) showed similar disease activity for retreatment with ultralow doses (200 mg and 500 mg per 6 months) compared with standard low-dose rituximab (RTX, 1000 mg per 6 …

nl, us (code pays fourni par la source)

Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial

Melissa F. Djodikromo, Rosella Hermens, Bart JF van den Bemt, Yolba Smit et autres

BACKGROUND: Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effectiveness while reducing adverse events and medication costs. As the choice for dose …

nl (code pays fourni par la source)

Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial

Renske C. F. Hebing, Marry Lin, Maja Bulatović Ćalasan, Ittai B. Muller et autres

nl (code pays fourni par la source)

The Effect of Self-Administration of Medication During Hospitalization on Patient’s Self-Efficacy and Medication Adherence After Discharge

Loes J. M. van Herpen‐Meeuwissen, Hein A. W. van Onzenoort, Patricia M. L. A. van den Bemt, Barbara Maat et autres

Purpose: The effect of self-administration of medication (SAM), in which capable hospitalized patients administer medication themselves on medication self-efficacy is inconclusive. The aim of this study was to evaluate the effect of SAM on medication self-efficacy, adherence and patient satisfaction. Patients and …

nl (code pays fourni par la source)

The association between patient satisfaction with information and adherence to oral anticancer agents

Eward J Melis, Jeannette EF Zwart-van Rijkom, Toine C. G. Egberts, Bart JF van den Bemt et autres

INTRODUCTION: Adherence to anticancer agents is a critical factor in achieving adequate clinical response, and became a major challenge for patients and caregivers since the increased substitution of parenteral cytostatic by oral drugs. One of the factors that influences adherence is how …

nl (code pays fourni par la source)

Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes

Leanne J. Kosse, Gerda Weits, Harald E. Vonkeman, Sander W. Tas et autres

Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patients’ real-world experience with drugs. Despite the leading role for patients, little is known about their perspectives on CEM systems. …

Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD

Evy Ulijn, Nathan den Broeder, Maike H M Wientjes, Noortje van Herwaarden et autres

nl (code pays fourni par la source)

PMD60 AN INNOVATIVE REUSABLE ELECTRONIC INJECTION DEVICE FOR CERTOLIZUMAB PEGOL: RESULTS FROM A PILOT MARKET RESEARCH STUDY EXAMINING PATIENT PREFERENCE AND SATISFACTION

Bart P. H. Pouls, Lars Erik Kristensen, M. Petersson, Bart JF van den Bemt et autres

nl, se, gb, be, de (code pays fourni par la source)

Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Lise M Verhoef, Bart JF van den Bemt, Aatke van der Maas, Johanna E Vriezekolk et autres

Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

nl (code pays fourni par la source)

Willingness of patients to use unused medications returned to the pharmacy by another patient

Charlotte Linde Bekker, Bart JF van den Bemt, Toine C. G. Egberts, Marcel L. Bouvy et autres

Background and objective: Redispensing by pharmacies of medications unused by another patient could contribute to optimal use of healthcare resources. Patient co-operation is essential for implementation of the redispensing process. However, insight into patient willingness to use redispensed medication is limited. This …

SAT0161 Majority of Patients do not Store Their Biological Disease Modifying Antirheumatic Drugs Within Recommended Temperature Range

Nicolaas D. Vlieland, Helga Rún Garðarsdóttir, Marcel L. Bouvy, Toine C. G. Egberts et autres

nl (code pays fourni par la source)